Perioperative handling of patients on antiplatelet therapy with need for surgery
Tóm tắt
Từ khóa
Tài liệu tham khảo
Steinhubl SR, Berger PB, Mann JT et al (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized trial (CREDO). JAMA 288:2411–2420
Chassot PG, Delabays A, Spahn D (2007) Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 99:316–328
Vicenzi MN, Meislitzer T, Heitzinger B et al (2006) Coronary artery stenting and non-cardiac surgery—a prospective outcome study. Br J Anaesth 96:686–693
Kaluza GL, Joseph J, Lee JR et al (2000) Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:1288–1294
Collet JP, Montalescot G, Blanchet B et al (2004) Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndrome. Circulation 110:2361–2367
McFadden EP, Stabile E, Regar E et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519–1521
Sharma AK, Ajani AE, Hamwi SM et al (2004) Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 63:141–145
Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126–2130
Murphy JT, Brenda GF (2005) Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit. Anesth Analg 101:971–973
Dawood MM, Gupta DK, Southern J et al (1996) Pathology of fatal perioperative myocardial infarction: implications regarding physiopathology and prevention. Int J Cardiol 57:37–44
Landesberg G (2003) The pathophysiology of perioperative myocardial infarction: facts and perspectives. J Cardiothorac Vasc Anesth 17:90–100
Priebe HJ (2004) Triggers of perioperative myocardial ischaemia and infarction. Br J Anaesth 93:9–20
Howard-Alpe GM, de Bono J, Hudsmith L, Orr WP, Foex P, Sear JW (2007) Coronary artery stents and non-cardiac surgery. Br J Anaesth 98:560–574
Maresca G, Di Blasio A, Marchioli R, Di Minno G (1999) Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update. Arterioscler Thromb Vasc Biol 19:1368–1377
Burger W, Chemnitius JM, Kneissl GD, Rücker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its preoperative withdrawal versus bleeding risks with its continuation—review and meta-analysis. J Int Med 257:399–414
Neilipovitz DT, Bryson GL, Nichol G (2001) The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 93:573–580
Manning BJ, O’Brien N, Aravindan S et al (2004) The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures. Injury 35:121–124
Nutall GA, Horlocker TT, Santrach PJ et al (2000) Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine 25:596–601
Nutall GA, Santrach PJ, Oliver WC Jr et al (1996) The predictors of red cell transfusions in total hip arthroplasties. Transfusion 36:144–149
Lindblad B, Persson NH, Takolander R, Bergqvist D (1993) Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind placebo-controlled, randomized study. Stroke 24:1125–1128
Stage J, Jensen JH, Bonding P (1988) Post-tonsillectomy haemorrhage and analgesics. A comparative study of acetylsalicylic acid and paracetamol. Clin Otolaryngol 13:201–204
Sandhu JS, Ng CK, Gonzales RR et al (2005) Photoselective laser vaporisation prostatectomy in men receiving anticoagulants. J Endourol 19:1196–1198
Palmer JD, Sparrow OC, Iannotti F (1994) Postoperative hematoma: a 5-year survey identification of avoidable risk factors. Neurosurgery 35:1061–1064
Antithrombotic Trialist’s Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 324:71–86
Yusuf S, Zhao F, Mehta SR, CURE Trial Investigators et al (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494–502
Kapetanakis EI, Medlam DA, Boyce SW et al (2005) Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist’s panacea or the surgeon’s headache? Eur Heart J 26:576–583
Yende S, Wunderink RG (2001) Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 29:2271–2275
Chu MWA, Wilson SR, Novick RJ et al (2004) Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 78:1536–1541
ACC/AHA (2002) Guideline update for perioperative cardiovascular evaluation for non-cardiac surgery—executive summary. Circulation 105:1257–1267
Broad L, Lee T, Conroy M et al (2007) Successful management of patients with a drug-eluting stent presenting for elective noncardiac surgery. Br J Anaesth 98:19–22
Brilakis ES, Orford JL, Fasseas P et al (2005) Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery. Am J Cardiol 96:512–514
Wilson SH, Fasseas P, Orford JL et al (2003) Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42:234–240
Ernst A, Eberhardt R, Wahidi M et al (2006) Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 129:734–737
Grines CL, Bonow RO, Casey DE et al (2007) Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A Science Advisory from the American Heart Association, American College of Cardiology, Society of Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 49:734–739
Qureshi A, Saad M, Zaidat OO et al (2002) Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 33:1916–1919
ACC/AHA/SCAI (2006) Guideline update for percutaneous coronary intervention. Executive summary. J Am Coll Cardiol 47:216–235
Biondi-Zoccai GGL, Lotrionte M, Agostini P et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50, 279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674
Hodgson JMCB, Stone GW, Lincoff AM et al (2007) Late stent thrombosis: considerations and practical advice for use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting stent Task Force (clinical alert). Catheter Cardiovasc Interv 69:327–333
Albaladejo P, Marret E, Piriou V, Samama CM (2006) Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force. Br J Anaesth 97:580–581
Silber S, Albertsson P, Avile`s FF et al (2005) Guidelines for percutaneous interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804–847
AHA/ACC (2006) Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 113:2363–2372
Kaiser C, Brunner-La Rocca HP, Buser PT et al (2005) Incremental cost-effectiveness of drug-eluting stents compared with a third generation bare-metal stent in a real world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 366:921–929
Ong ATL, McFadden EP, Regar E et al (2005) Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45:2088–2092
Pfisterer M, Brunner-La Rocca HP, Buser PT et al (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. J Am Coll Cardiol 48:2584–2591
Ferrari E, Benhamou M, Cerboni P, Marcel B (2005) Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 45:456–459
Meier P, Zbinden R, Togni M et al (2007) Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol 49:15–20
Spertus JA, Kettelkamp R, Vance C et al (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Circulation 113:2803–2809
Camenzind E, Steg PG, Wijns W (2007) Stent thrombosis late after implantation of first-generation drug-eluting stents. A cause of concern. Circulation 115:1440–1455
Eisenstein EL, Anstrom KJ, Kong DF et al (2007) Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297:159–168
Heeschen C, Hamm CW, Laufs U et al (2002) Withdrawal of statins increases event rates in patient with acute coronary syndromes. Circulation 105:1446–1452
Kersten JR, Fleisher LA (2006) Statins: the next advance in cardioprotection? Anesthesiology 105:1079–1080
Popma JJ, Berger P, Ohman EM et al (2004) Antithrombotic therapy during percutaneous coronary intervention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:576S–599S
Michlig C, Vu DH, Wasserfallen JB et al (2003) Three years of haemovigilance in a general university hospital. Transfus Med 13:63–72
Kearon C, Hirsh J (1997) Current concepts: management of anticoagulation before and after elective surgery. N Engl J Med 336:1506–1511
Horlocker TT, Wedel DJ, Benson H (2003) Regional anesthesia in anticoagulated patients: defining the risks. Reg Anesth Pain Med 28:172–198
Tam NLK, Pac-Soo C, Pretorius PM (2006) Epidural haematoma after a combined spinal-epidural anaesthetic in a patient treated with clopidogrel and dalteparin. Br J Anaesth 96:262–265
Tyagi A, Bhattacharya A (2002) Central neuraxial blocks and anticoagulation: a review of current trends. Eur J Anaesthesiol 19:317–329
Beattie WS, Badner NH, Choi P (2001) Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg 93:853–858
Park WY, Thompson JS, Lee KK (2001) Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veteran Affairs cooperative study. Ann Surg 234:560–569
Ollausson K, Magnusdottir H, Lurje L et al (1997) Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris. Circulation 96:2178–2182
Samama CM (2007) Preoperative nonsteroidal antiinflammatory agents as substitutes for aspirin. Already too late? Anesthesiology 106:205–206
Newsome LT, Kutcher MA, Gandhi SK, Prielipp RC, Royster RL (2006) A protocol for the perioperative management of patients with intracoronary drug-eluting stents. Anesthesia Patient Safety Foundation. APSF Newsl 4:81–82
Samama CM, Djoudi R, Lecompte T, Nathan N, Schved JF (2006) Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency 2003. Minerva Anesthesiol 72:447–452
Di Minno G, Silver MJ, Murphy S (1983) Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood 61:1081–1085
Van der Linden J, Lindvall G, Sartipy U (2005) Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. Circulation 112:1276–1280
Auerbach A, Goldman L (2006) Assessing and reducing the cardiac risk of non-cardiac surgery. Circulation 113:1361–1376
Agostini P, Biondi-Zoccai GGL, Gasparini GL et al (2005) Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials. Eur Heart J 26:881–889